Popat, U. R., Bassett, R. L., Thall, P. F., Alousi, A. M., Alatrash, G., Bashir, Q., Hosing, C. M., Im, J. S., Kebriaei, P., Marin, D., Mehta, R. S., Nieto, Y., Olson, A. L., Oran, B., Valdez, B., Qazilbash, M. H., Champlin, R. E., Shpall, E. J., Andersson, B. S. (2025). Myeloablative fractionated busulfan conditioning regimen with sorafenib for allogeneic stem cell transplant in AML: Results of a phase 1/2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.6561